Business

Anne Wojcicki DNA-testing start-up 23andMe is experimenting with a new way to collect a lot more health data from millions of its users than just their DNA. The company is now asking a subset of customers if they’d be willing to incorporate their lab results, prescription information and medical history, after they’ve received the results
0 Comments
President Donald Trump Jabin Botsford | The Washington Post | Getty Images Pharmaceutical companies may be in the direct path of President Donald Trump‘s next big policy push to lower drug prices after the administration abandoned a proposal that would have eliminated rebates from government drug plans. Earlier Thursday, the White House said the Trump
0 Comments